| TYKR TYKR LLC
90760467 08 Jun 2021 | on 04 Oct 2022
| Platform as a service (PAAS) featuring computer software platforms for... Class 042 Class 042 Computer & Software Services & Scientific Services TICKER | | | TYKR Tykr
98525295 29 Apr 2024 | on 20 Nov 2024 | Educational services, namely, providing online courses of instruction ... Class 036 Class 036 Insurance & Financial Services Educational services, namely, providing online courses of instruction at the primary, secondary, college level and distribution of course material in connection therewith Class 041 Class 041 Education and Entertainment Services Providing an on-line computer database in the field of stock/securities market information | | | TYKRUVA Bristol-Myers Squibb Company
90387051 16 Dec 2020 | on 11 Dec 2024 | Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use for immunotherapy, including T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use | | | TYKRAVA Bristol-Myers Squibb Company
98843463 08 Nov 2024 | on 08 Nov 2024 | Pharmaceutical and biological preparations for human use. Class 005 Class 005 Pharmaceutical Products Pharmaceutical and biological preparations for human use. | | | TYKRON Roberts-Gordon, Inc.
74406152 28 Jun 1993 | on 29 Dec 2001 | source capture fume exhaust equipment; namely, air cleaners and purifi... Class 011 Class 011 Environmental Control Instrument Products (lighting,heating,cooling,cooking) source capture fume exhaust equipment; namely, air cleaners and purifiers for industrial use | | | TYKRAVA Bristol-Myers Squibb Company
90240885 07 Oct 2020 | on 16 Dec 2024
| Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for use in disease testing | |